| |
| |
|
| Insider
Information: |
Holler Frank A |
| Relationship: |
Director |
| City: |
Burnaby |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
143,653 |
|
|
Indirect Shares
|
1,184 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
144,837 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenon Pharmaceuticals Inc. |
XENE |
Director |
2021-05-27 |
143,653 |
2021-05-27 |
1,184 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-05-27 |
4 |
S |
$18.68 |
$206,701 |
D/D |
(11,064) |
143,653 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-05-27 |
4 |
D |
$18.88 |
$121,172 |
D/D |
(6,418) |
154,717 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-05-27 |
4 |
OE |
$3.76 |
$146,993 |
D/D |
39,094 |
160,628 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2020-05-29 |
4 |
OE |
$3.56 |
$10,986 |
D/D |
3,086 |
122,041 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-09-20 |
4 |
S |
$9.39 |
$48,884 |
D/D |
(5,206) |
118,955 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-09-19 |
4 |
S |
$9.27 |
$70,452 |
D/D |
(7,600) |
124,161 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-09-18 |
4 |
S |
$9.28 |
$40,535 |
D/D |
(4,368) |
131,761 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-09-17 |
4 |
S |
$9.32 |
$47,243 |
D/D |
(5,069) |
136,129 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-09-12 |
4 |
D |
$9.38 |
$90,508 |
D/D |
(9,649) |
141,198 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-09-12 |
4 |
OE |
$3.00 |
$98,052 |
D/D |
31,892 |
148,979 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2018-03-14 |
4 |
OE |
$3.77 |
$11,634 |
D/D |
3,086 |
118,955 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2016-12-15 |
4 |
S |
$7.85 |
$235,500 |
D/D |
(30,000) |
115,869 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2016-08-19 |
4 |
S |
$7.65 |
$91,338 |
D/D |
(11,938) |
145,869 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2016-08-18 |
4 |
S |
$7.70 |
$73,912 |
D/D |
(9,599) |
157,807 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2016-08-17 |
4 |
S |
$7.89 |
$12,624 |
D/D |
(1,600) |
167,406 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2016-08-16 |
4 |
S |
$8.25 |
$56,620 |
D/D |
(6,863) |
169,006 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-11-24 |
4 |
D |
$9.39 |
$9,343 |
D/D |
(995) |
175,869 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-11-24 |
4 |
OE |
$5.22 |
$10,738 |
D/D |
2,057 |
176,864 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-08-18 |
4 |
OE |
$4.98 |
$10,244 |
D/D |
2,057 |
175,675 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-08-18 |
4 |
D |
$11.00 |
$9,548 |
D/D |
(868) |
174,807 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2014-11-09 |
4 |
A |
$0.00 |
$0 |
I/I |
941 |
1,184 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2014-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
102,727 |
173,618 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2014-11-04 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
243 |
|
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2014-11-04 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
70,891 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
